Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.044 USD | -4.46% | +7.32% | -28.46% |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 176M |
---|---|---|---|---|---|
Net income 2021 | -122M | Net income 2022 | -115M | EV / Sales 2021 | - |
Net cash position 2021 | 12.15M | Net Debt 2022 | 3.2M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.63
x | P/E ratio 2022 |
-1.23
x | Employees | 66 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.86% |
Latest transcript on Evelo Biosciences, Inc.
1 day | -4.46% | ||
1 week | +7.32% | ||
Current month | -2.22% | ||
1 month | -21.43% | ||
3 months | -34.33% | ||
6 months | -96.33% | ||
Current year | -28.46% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | Nov. 20 |
Andrea Itano
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Duncan McHale
CTO | Chief Tech/Sci/R&D Officer | 57 | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | Nov. 20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 0.044 | -4.46% | 61,379 |
24-04-16 | 0.046 | +2.22% | 20,504 |
24-04-15 | 0.045 | -10.89% | 14,102 |
24-04-12 | 0.0505 | +23.17% | 1,168 |
24-04-11 | 0.041 | 0.00% | 35,183 |
Delayed Quote OTC Markets, April 17, 2024 at 03:23 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-28.46% | 834K | |
-3.39% | 102B | |
+2.61% | 96.84B | |
-1.02% | 21.48B | |
-18.14% | 20.82B | |
-6.87% | 18.6B | |
-40.70% | 16.81B | |
-26.89% | 13.78B | |
+1.12% | 13.4B | |
+22.25% | 11.06B |
- Stock Market
- Equities
- EVLO Stock